Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-09-09 02:48:15 UTC |
---|
Update Date | 2022-11-30 19:25:55 UTC |
---|
HMDB ID | HMDB0114819 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | PA(15:0/20:0) |
---|
Description | PA(15:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
---|
Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC InChI=1S/C38H75O8P/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-38(40)46-36(35-45-47(41,42)43)34-44-37(39)32-30-28-26-24-22-16-14-12-10-8-6-4-2/h36H,3-35H2,1-2H3,(H2,41,42,43)/t36-/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-pentadecanoyl-2-arachidoyl-sn-glycero-3-phosphate | SMPDB, HMDB | 1-pentadecanoyl-2-arachidoyl-sn-phosphatidic acid | SMPDB, HMDB | PA(35:0) | SMPDB, HMDB | Phosphatidic acid(15:0/20:0) | SMPDB, HMDB | Phosphatidic acid(35:0) | SMPDB, HMDB | Phosphatidate(15:0/20:0) | SMPDB, HMDB | Phosphatidate(35:0) | SMPDB, HMDB | PA(15:0/20:0) | SMPDB |
|
---|
Chemical Formula | C38H75O8P |
---|
Average Molecular Weight | 690.984 |
---|
Monoisotopic Molecular Weight | 690.519956373 |
---|
IUPAC Name | [(2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphonic acid |
---|
Traditional Name | (2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxyphosphonic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC |
---|
InChI Identifier | InChI=1S/C38H75O8P/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-38(40)46-36(35-45-47(41,42)43)34-44-37(39)32-30-28-26-24-22-16-14-12-10-8-6-4-2/h36H,3-35H2,1-2H3,(H2,41,42,43)/t36-/m1/s1 |
---|
InChI Key | RLTVMKPFQGJWBS-PSXMRANNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphates |
---|
Direct Parent | 1,2-diacylglycerol-3-phosphates |
---|
Alternative Parents | |
---|
Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/14:1(9Z)) (PathBank: SMP0016190)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/15:0) (PathBank: SMP0017024)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/16:0) (PathBank: SMP0017025)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:0) (PathBank: SMP0017026)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:0) (PathBank: SMP0017027)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:0) (PathBank: SMP0017028)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/24:0) (PathBank: SMP0017029)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/16:1(9Z)) (PathBank: SMP0017030)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:1(11Z)) (PathBank: SMP0017031)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:1(9Z)) (PathBank: SMP0017032)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:1(11Z)) (PathBank: SMP0017033)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0017034)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:1(13Z)) (PathBank: SMP0017035)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/24:1(15Z)) (PathBank: SMP0017036)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:2(9Z,12Z)) (PathBank: SMP0017037)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0017038)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0017039)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:2(13Z,16Z)) (PathBank: SMP0017040)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0017041)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0017042)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0017043)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0017044)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0017045)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0017046)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0017047)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0017048)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:2(11Z,14Z)) (PathBank: SMP0032643)
- De Novo Triacylglycerol Biosynthesis TG(15:0/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0032644)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/20:0) (PathBank: SMP0098168)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/20:1(11Z)) (PathBank: SMP0098169)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098170)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098171)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/22:0) (PathBank: SMP0098172)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:0/22:1(13Z)) (PathBank: SMP0098173)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:1(11Z)/20:1(11Z)) (PathBank: SMP0098174)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098175)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098176)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:1(11Z)/22:0) (PathBank: SMP0098177)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:1(11Z)/22:1(13Z)) (PathBank: SMP0098178)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098179)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098180)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0098181)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0098182)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098183)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0098184)
- Cardiolipin Biosynthesis CL(15:0/20:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0098185)
- Cardiolipin Biosynthesis CL(15:0/20:0/22:0/22:0) (PathBank: SMP0098186)
- Cardiolipin Biosynthesis CL(15:0/20:0/22:0/22:1(13Z)) (PathBank: SMP0098187)
- Cardiolipin Biosynthesis CL(15:0/20:0/22:1(13Z)/22:1(13Z)) (PathBank: SMP0098188)
|
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
PA(15:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4802.8 | Semi standard non polar | 33892256 | PA(15:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4360.0 | Standard non polar | 33892256 | PA(15:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5906.5 | Standard polar | 33892256 | PA(15:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4773.7 | Semi standard non polar | 33892256 | PA(15:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4364.8 | Standard non polar | 33892256 | PA(15:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 5147.6 | Standard polar | 33892256 | PA(15:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5074.6 | Semi standard non polar | 33892256 | PA(15:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4473.1 | Standard non polar | 33892256 | PA(15:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5861.2 | Standard polar | 33892256 |
|
---|
General References | - Moritz A, De Graan PN, Gispen WH, Wirtz KW: Phosphatidic acid is a specific activator of phosphatidylinositol-4-phosphate kinase. J Biol Chem. 1992 Apr 15;267(11):7207-10. [PubMed:1313792 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Divecha N, Irvine RF: Phospholipid signaling. Cell. 1995 Jan 27;80(2):269-78. [PubMed:7834746 ]
- Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Bierman AJ, de Laat SW: Growth factor-like action of phosphatidic acid. Nature. 1986 Sep 11-17;323(6084):171-3. [PubMed:3748188 ]
- Yang CY, Frohman MA: Mitochondria: signaling with phosphatidic acid. Int J Biochem Cell Biol. 2012 Aug;44(8):1346-50. doi: 10.1016/j.biocel.2012.05.006. Epub 2012 May 15. [PubMed:22609101 ]
- Cevc, Gregor (1993). Phospholipids Handbook. Marcel Dekker.
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|